希瑪醫療控股有限公司（03309）於2025年11月25日公布翌日披露報表，披露該公司於同日透過香港聯交所回購股份200,000股，約佔回購前已發行股本的0.0161%。根據公告，回購價格區間為每股1.71至1.73港元，涉及總金額約344,080港元。
回購完成後，公司已發行股本總數維持1,255,560,870股，其中1,238,272,870股為已發行股份，庫藏股份則增至17,288,000股。公告同時顯示，該公司於2025年5月19日獲股東大會通過回購授權，獲允許回購最多125,556,087股股份。截至目前，本次回購數量佔該授權總數的約0.0161%。
公司在公告中確認，所有回購行為均遵循香港聯交所《主板上市規則》等相關法例及授權決議。公告由公司秘書陳華平簽署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.